- Home
- RNAZ vs PET Comparison
RNAZ vs PET Comparison
Compare RNAZ & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- PET
- Stock Information
- Founded
- RNAZ 2016
- PET 2015
- Country
- RNAZ United States
- PET United States
- Employees
- RNAZ N/A
- PET N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- PET EDP Services
- Sector
- RNAZ Health Care
- PET Technology
- Exchange
- RNAZ Nasdaq
- PET Nasdaq
- Market Cap
- RNAZ 6.1M
- PET 5.9M
- IPO Year
- RNAZ 2021
- PET N/A
- Fundamental
- Price
- RNAZ $7.97
- PET $0.11
- Analyst Decision
- RNAZ Strong Buy
- PET Strong Buy
- Analyst Count
- RNAZ 1
- PET 3
- Target Price
- RNAZ $280.00
- PET $4.17
- AVG Volume (30 Days)
- RNAZ 32.8K
- PET 4.6M
- Earning Date
- RNAZ 08-13-2025
- PET 08-06-2025
- Dividend Yield
- RNAZ N/A
- PET N/A
- EPS Growth
- RNAZ N/A
- PET N/A
- EPS
- RNAZ N/A
- PET N/A
- Revenue
- RNAZ N/A
- PET $62,453,000.00
- Revenue This Year
- RNAZ N/A
- PET $7.87
- Revenue Next Year
- RNAZ N/A
- PET $122.23
- P/E Ratio
- RNAZ N/A
- PET N/A
- Revenue Growth
- RNAZ N/A
- PET N/A
- 52 Week Low
- RNAZ $6.15
- PET $0.08
- 52 Week High
- RNAZ $970.20
- PET $1.79
- Technical
- Relative Strength Index (RSI)
- RNAZ 47.04
- PET 42.91
- Support Level
- RNAZ $7.32
- PET $0.09
- Resistance Level
- RNAZ $8.48
- PET $0.13
- Average True Range (ATR)
- RNAZ 0.58
- PET 0.01
- MACD
- RNAZ 0.41
- PET -0.00
- Stochastic Oscillator
- RNAZ 70.77
- PET 30.45
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.